Most aggregation-induced emission (AIE) luminogens exhibit
high
brightness, excellent photostability, and good biocompatibility, but
these AIE-active agents, which kill two birds with one stone to result
in applications in both stimulated emission depletion (STED) super-resolution
imaging and photodynamic therapy (PDT), have not been reported yet
but are urgently needed. To meet the requirements of STED nanoscopy
and PDT, D-A-π-A-D type DTPABT-HP is designed by tuning conjugated
π spacers. It exhibits red-shifted emission, high PLQY of 32.04%,
and impressive 1O2 generation (9.24 fold compared
to RB) in nanoparticles (NPs). Then, DTPABT-HP NPs are applied in
cell imaging via STED nanoscopy, especially visualizing
the dynamic changes of lysosomes in the PDT process at ultrahigh resolution.
After that, in vivo PDT was also conducted by DTPABT-HP
NPs, resulting in significantly inhibited tumor growth, with an inhibition
rate of 86%. The work here is beneficial to the design of multifunctional
agents and the deep understanding of their phototheranostic mechanism
in biological research.